Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.48 |
| ▸ | CASP1 | P29466 | 3/20 | 0.46 |
| ▸ | CASP7 | P55210 | 2/20 | 0.46 |
| ▸ | HBB | P68871 | 2/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | PLAU | P00749 | 2/20 | 0.43 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | F2 | P00734 | 1/20 | 0.41 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.41 |
| ▸ | HTR1A | P08908 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31722811 | 1.00 | ALDH1A1 (0.48) | ALDH1A1HSD17B10CYP3A4CASP1CASP7 | |
| SCHEMBL21409802 | 0.93 | PLAU (0.44) | ALDH1A1HSD17B10CYP3A4CASP1CASP7 | |
| SCHEMBL29463756 | 0.82 | PLAU (0.45) | ALDH1A1HSD17B10CYP3A4CASP1CASP7 | |
| SCHEMBL678473 | 0.82 | PLAU (0.45) | ALDH1A1HSD17B10CYP3A4CASP1CASP7 | |
| SCHEMBL29389942 | 0.82 | PLAU (0.45) | ALDH1A1HSD17B10CYP3A4CASP1CASP7 | |
| SCHEMBL17323165 | 0.79 | ALDH1A1 (0.56) | ALDH1A1HSD17B10CYP3A4CASP1CASP7 | |
| SCHEMBL2445157 | 0.78 | ALDH1A1 (0.57) | ALDH1A1HSD17B10CYP3A4CASP1CASP7 | |
| SCHEMBL21499706 | 0.78 | HPRT1 (0.43) | ALDH1A1HSD17B10CYP3A4CASP1CASP7 | |
| SCHEMBL14742694 | 0.77 | ALDH1A1 (0.50) | ALDH1A1HSD17B10CYP3A4CASP1CASP7 | |
| SCHEMBL5514092 | 0.76 | ALDH1A1 (0.44) | ALDH1A1HSD17B10CYP3A4CASP1CASP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4390596-A | POLYAMINE, BIS-MALEIMIDE, FREE RADICAL CATALYST, FILLER | RHONE-POULENC INDUSTRIES (FR) | 1983-06-28 | — | — | US | claimed |
| US-4238591-A | BIS-MALEIMIDE, SILANEDIOL OR SILOXANE | RHONE-POULENC INDUSTRIES (FR) | 1980-12-09 | — | — | US | claimed |
| US-4225498-A | Preparation of N-substituted oligo-imides | RHONE-POULENC INDUSTRIES (FR) | 1980-09-30 | — | — | US | claimed |
| CN-111886278-A | Triazine ring-containing polymer, resin composition, cured film, and solid-state imaging element | 东丽株式会社 | 2020-11-03 | — | — | CN | disclosed |
| US-10793584-B2 | Naphthobischalcogenadiazole derivative and production method therefor | OSAKA UNIVERSITY (JP) | 2020-10-06 | — | — | US | disclosed |
| EP-0710684-B1 | Preparation process of polyhydroxycarboxylic acid | MITSUI CHEMICALS INC (JP) | 2001-01-31 | — | — | EP | disclosed |
| US-5770683-A | Preparation process of polyhydroxycarboxylic acid | MITSUI TOATSU CHEMICALS, INC. (JP) | 1998-06-23 | — | — | US | disclosed |
| EP-0710684-A2 | Preparation process of polyhydroxycarboxylic acid | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1996-05-08 | — | — | EP | disclosed |
| EP-0182919-B1 | THERMOSETTING RESIN COMPOSITION | MITSUI PETROCHEMICAL IND (JP) | 1994-12-28 | — | — | EP | disclosed |
| EP-0526490-B1 | TEMPERATURE AND SOLVENT-RESISTANT INK FOR THE INK-JET PRINTING PROCESS | BECK & CO AG DR (DE) | 1994-07-20 | — | — | EP | disclosed |
| EP-0310424-B1 | Thermosetting resin composition | MITSUI PETROCHEMICAL IND (JP) | 1994-01-05 | — | — | EP | disclosed |
| US-4012361-A | Heat-stable polyimide resins from a bis-imide, a polyamine and an alazine | RHONE-POULENC S.A. (FR) | 1977-03-15 | — | — | US | disclosed |
| US-4010220-A | AMINO COMPOUND, POLYURETHANE ELASTOMER | RHONE-POULENC INDUSTRIES (FR) | 1977-03-01 | — | — | US | disclosed |
| US-4005154-A | Curing 1,2-epoxy with prepolymer based on polyamines and oligomers possessing imide groups | RHONE-POULENC S.A. (FR) | 1977-01-25 | — | — | US | disclosed |
| US-3998904-A | POLYAMINES WITH IMIDE GROUPS | RHONE-POULENC S.A. (FR) | 1976-12-21 | — | — | US | disclosed |
| US-3978152-A | HEAT-RESISTANT RESINS DERIVED FROM A BIS-IMIDE, AN EPOXY RESIN AND A POLYAMINE | RHONE-POULENC INDUSTRIES (FR) | 1976-08-31 | — | — | US | disclosed |
| US-3970714-A | Heat-stable polyimide resin modified by unsaturated polyester | RHONE-POULENC S.A. (FR) | 1976-07-20 | — | — | US | disclosed |
| US-3966678-A | Maleic anhydride-polyaldimine prepolymers | RHONE-POULENC S.A. (FR) | 1976-06-29 | — | — | US | disclosed |
| US-3950279-A | DI- OR TRI-MALEIMIDE, AZOMETHINE, SOLID FOAMING AGENT | CIBA-GEIGY CORPORATION (US) | 1976-04-13 | — | — | US | disclosed |
| US-3947385-A | Mixtures containing prepolymers, which can be converted to heat-resistant foamed plastics | CIBA-GEIGY CORPORATION (US) | 1976-03-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10793584-B2 | Naphthobischalcogenadiazole derivative and production method therefor | CYP24A1, CYP26B1, CYP21A2 | ALDH1A1 600/4885HSD17B10 947/4885CYP3A4 389/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.